Literature DB >> 22818113

Validation of the Stroke-specific Quality of Life for patients after aneurysmal subarachnoid hemorrhage and proposed summary subscores.

George Kwok Chu Wong1, Sandy Wai Lam, Karine Ngai, Adrian Wong, Wai Sang Poon, Vincent Mok.   

Abstract

BACKGROUND: The identification of aneurysmal subarachnoid hemorrhage (aSAH) patients with a decrease in health-related quality of life (HRQOL) is challenging. Failure of clinical trials has been partially attributed to lack of sensitivity in outcome measures. Stroke-specific Quality of Life (SS-QOL) is a disease-specific HRQOL tool widely applied in ischemic stroke researches, but not in aSAH. AIM: This study aimed to validate a Chinese version of SSQOL (SS-QOL-CH) for aSAH patients and proposed summary scores for clinical application.
METHODS: We carried out a prospective observational assessor-blinded multi-center study in Hong Kong. One hundred and four Chinese adults were recruited into the current study, and assessments of the outcome of aSAH patients were made 3months after ictus.
RESULTS: Internal consistency was good and supported convergent validity for 12 domains of the SS-QOL-CH, with Cronbach's α coefficients ranging from 0.73 to 0.98. Principal component analyses suggested a two-component solution to explain a total of 65% variance. The two-component solution showed no significant floor or ceiling effects in our aSAH population. Validity of the criteria for the physical and psychosocial subtotal scores showed relevant and distinct correlations with other outcome measures.
CONCLUSIONS: Dichotomization of physical and psychosocial subtotal scores is valid and can simplify applications of the scale.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22818113     DOI: 10.1016/j.jns.2012.06.025

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group.

Authors:  Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

2.  Comparison of construct validity of two short forms of Stroke-Specific Quality of Life scale.

Authors:  Chia-Yeh Chou; Chien-Yu Huang; Yi-Jing Huang; Gong-Hong Lin; Sheau-Ling Huang; Shu-Chun Lee; Ching-Lin Hsieh
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

3.  Effect of transcranial direct current stimulation of stroke patients on depression and quality of life.

Authors:  Tae-Gyu An; Soo-Han Kim; Ko-Un Kim
Journal:  J Phys Ther Sci       Date:  2017-03-22

4.  Patient-reported outcome measures in subarachnoid hemorrhage: A systematic review.

Authors:  Edith Nobels-Janssen; Philip J van der Wees; Wim I M Verhagen; Gert P Westert; Ronald H M A Bartels; Jeroen D Boogaarts
Journal:  Neurology       Date:  2019-05-10       Impact factor: 9.910

Review 5.  Made to measure-Selecting outcomes in aneurysmal subarachnoid hemorrhage research.

Authors:  Christopher R Andersen; Shane W English; Anthony Delaney
Journal:  Front Neurol       Date:  2022-09-21       Impact factor: 4.086

6.  Validity, reliability and Norwegian adaptation of the Stroke-Specific Quality of Life (SS-QOL) scale.

Authors:  Synne Garder Pedersen; Guri Anita Heiberg; Jørgen Feldbæk Nielsen; Oddgeir Friborg; Henriette Holm Stabel; Audny Anke; Cathrine Arntzen
Journal:  SAGE Open Med       Date:  2018-01-08

7.  Validity and reliability of a Nigerian-Yoruba version of the stroke-specific quality of life scale 2.0.

Authors:  Marufat Oluyemisi Odetunde; Aderonke Omobonike Akinpelu; Adesola Christiana Odole
Journal:  Health Qual Life Outcomes       Date:  2017-10-19       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.